41 related articles for article (PubMed ID: 3179034)
1. Model Systems for Understanding Mechanisms of Nongenotoxic Carcinogenesis: Response.
Braeuning A; Henderson CJ; Wolf CR; Schwarz M
Toxicol Sci; 2015 Oct; 147(2):299-300. PubMed ID: 26668886
[No Abstract] [Full Text] [Related]
2. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
[TBL] [Abstract][Full Text] [Related]
3. A semipurified diet that suppresses phenobarbital promotion of hepatocarcinogenesis in the rat.
Hendrich S; Glauert HP; Pitot HC
Nutr Cancer; 1989; 12(3):249-58. PubMed ID: 2771802
[TBL] [Abstract][Full Text] [Related]
4. The effect of the format of administration and the total dose of phenobarbital on altered hepatic foci following initiation in female rats with diethylnitrosamine.
Xu YD; Dragan YP; Young T; Pitot HC
Carcinogenesis; 1991 Jun; 12(6):1009-16. PubMed ID: 2044180
[TBL] [Abstract][Full Text] [Related]
5. Quantitative stereologic study of the effects of varying the time between initiation and promotion on four histochemical markers in rat liver during hepatocarcinogenesis.
Xu YH; Maronpot R; Pitot HC
Carcinogenesis; 1990 Feb; 11(2):267-72. PubMed ID: 1967985
[TBL] [Abstract][Full Text] [Related]
6. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
Pitot HC; Goldsworthy TL; Moran S; Kennan W; Glauert HP; Maronpot RR; Campbell HA
Carcinogenesis; 1987 Oct; 8(10):1491-9. PubMed ID: 2888545
[TBL] [Abstract][Full Text] [Related]
7. The effects of dose and duration of administration on the promotion index of phenobarbital in multistage hepatocarcinogenesis in the rat.
Rizvi TA; Kennan W; Xu YH; Pitot HC
APMIS Suppl; 1988; 2():262-74. PubMed ID: 3179034
[TBL] [Abstract][Full Text] [Related]
8. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat.
Pitot HC; Campbell HA; Maronpot R; Bawa N; Rizvi TA; Xu YH; Sargent L; Dragan Y; Pyron M
Toxicol Pathol; 1989; 17(4 Pt 1):594-611; discussion 611-2. PubMed ID: 2697939
[TBL] [Abstract][Full Text] [Related]
9. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
Kunz W; Schaude G; Schwarz M; Tennekes H
Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
[No Abstract] [Full Text] [Related]
10. Quantitation of multistage carcinogenesis in rat liver.
Pitot HC; Dragan YP; Teeguarden J; Hsia S; Campbell H
Toxicol Pathol; 1996; 24(1):119-28. PubMed ID: 8839289
[TBL] [Abstract][Full Text] [Related]
11. Mouse liver tumors and microsomal enzyme-inducing drugs: experimental and clinical perspectives with phenobarbital.
McClain RM
Prog Clin Biol Res; 1990; 331():345-65. PubMed ID: 2156272
[No Abstract] [Full Text] [Related]
12. Altered hepatic foci: their role in murine hepatocarcinogenesis.
Pitot HC
Annu Rev Pharmacol Toxicol; 1990; 30():465-500. PubMed ID: 2188576
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
